Assessing the impact of personalised risk estimates on the uptake and timing of risk management options in women who have inherited a change in genes associated with an increased risk of breast and ovarian cancer
Not Applicable
- Conditions
- Hereditary breast and ovarian cancerCancer
- Registration Number
- ISRCTN15331714
- Brief Summary
2022 Protocol article in https://doi.org/10.3390/cancers14112716 (added 21/06/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- Female
- Target Recruitment
- 600
Inclusion Criteria
1. Female
2. Age >18 years
3. Undergoing predictive testing for a PV in BRCA1, BRCA2, PALB2, ATM or CHEK2
4. Able to give informed consent
Exclusion Criteria
Previous history of breast cancer or ovarian cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method